Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Prestige Consumer Healthcare (PBH) Gross Margin (2016 - 2025)

Prestige Consumer Healthcare has reported Gross Margin over the past 16 years, most recently at 55.52% for Q4 2025.

  • For Q4 2025, Gross Margin rose 5.0% year-over-year to 55.52%; the TTM value through Dec 2025 reached 56.12%, up 100.0%, while the annual FY2025 figure was 55.76%, 28.0% up from the prior year.
  • Gross Margin for Q4 2025 was 55.52% at Prestige Consumer Healthcare, roughly flat from 55.3% in the prior quarter.
  • Over five years, Gross Margin peaked at 59.07% in Q2 2021 and troughed at 53.79% in Q1 2023.
  • A 5-year average of 55.99% and a median of 55.71% in 2022 define the central range for Gross Margin.
  • Biggest five-year swings in Gross Margin: tumbled -242bps in 2023 and later surged 253bps in 2025.
  • Year by year, Gross Margin stood at 56.49% in 2021, then decreased by -3bps to 54.59% in 2022, then increased by 2bps to 55.86% in 2023, then fell by -1bps to 55.47% in 2024, then increased by 0bps to 55.52% in 2025.
  • Business Quant data shows Gross Margin for PBH at 55.52% in Q4 2025, 55.3% in Q3 2025, and 56.24% in Q2 2025.